GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2026 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the GeneDx Holdings Corp. First Quarter 2026 Earnings Conference Call.
Genedx Holdings Corp. (WGS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 689,290 | $44,266,204 | +16% | 6.13% |
| 2. | Bayforest Capital Theodoros Tsagaris | 246 | $15,798 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.06 | 29,236 | $2,399,106.16 | 3,228,150 | 2026-03-05 | Filing | |
| $81.37 | 60,892 | $4,954,782.04 | 3,198,914 | 2026-03-05 | Filing | |
| $80.55 | 47,623 | $3,836,032.65 | 3,138,022 | 2026-03-05 | Filing | |
| $78.91 | 1,971 | $155,531.61 | 3,090,399 | 2026-03-05 | Filing | |
| $77.96 | 304 | $23,699.84 | 3,088,428 | 2026-03-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $64.12 | 18 | $1,154.16 | 93,216 | 2026-04-29 | Filing | |
| $65.20 | 2,154 | $140,440.80 | 93,234 | 2026-04-29 | Filing | |
| $65.19 | 392 | $25,555.50 | 34,942 | 2026-04-29 | Filing | |
| $65.21 | 1,857 | $121,102.96 | 34,580 | 2026-03-26 | Filing | |
| $64.60 | 995 | $64,276.30 | 36,437 | 2026-03-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 858,583 | $55,138,200 | 0% | |
| 2. | 775,269 | $49,787,775 | 0.16% | |
| 3. | 638,800 | $41,023,736 | 0.58% | |
| 4. | 633,457 | $40,680,609 | 0.03% | |
| 5. | 315,508 | $20,261,884 | 0% |
News See All
Do You Believe in GeneDx Holdings Corp.’s (WGS) Durable Competitive Moat?
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
10 Best Diagnostics and Research Stocks to Buy According to Analysts
The diagnostics and research sector holds a crucial position in the healthcare ecosystem, thus attracting investor interest.
15 Most Promising Stocks Under $100 to Buy
On March 12, Roger Ferguson, former Fed Vice Chair, joined 'Closing Bell' on CNBC to discuss what to expect from the Federal Reserve next week.
GeneDx Holdings Corp. (WGS): A Bull Case Theory
We came across a bullish thesis on GeneDx Holdings Corp. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on WGS.
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Holdings Corp. Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
GeneDx Holdings Corp. (WGS) Surged Following Strong Earnings and Improved Guidance
Polen Capital, an investment management company, released its fourth-quarter investor letter for “Polen 5Perspectives Small Growth Strategy”. A copy of the letter can be downloaded here.
WellsFargo Upgrades GeneDx (WGS) to Overweight
WellsFargo upgraded its rating on GeneDX to Overweight (from Equal Weight) on February 9, while retaining the target price at $155.
13 High-Risk High-Reward Growth Stocks to Invest In
“Will the US Fed cut rates?” seems to be the question everyone is asking after the release of the January US jobs report on February 11, which showed a stronger-than-expected labor market.
What Do Analysts Think About GeneDx Holdings Corp. (WGS)?
TheFly reported that on December 22, 2025, GeneDx Holdings Corp. (NASDAQ:WGS) lifted its price objective at Canaccord from $160 to $170. Canaccord continued to rate the shares as a Buy.
Hedge Fund Resource Center